Torrent Pharmaceuticals Limited has informed the Exchange about Presentation to analysts on unaudited Consolidated Financial Results for the quarter ended 30th June, 2022

m;orrenr w PHARffiA

29th July, 2022

The Dy. General Manager (Listing Dept.) BSE Limited, Corporate Relationship Dept., 1st Floor, New Trading Ring, P. J. Towers, Dalal Street, Fort, Mumbai - 400 001 (BSE Scrip Cod.e: 500420)

The Manager - Listing Dept.,· National Stock Exchange oflndia Ltd., Exchange Plaza, 5th Floor, Plot No. C/1, G. Block, Bandra - Kurla Complex, Bandra (E), Mumbai - 400 051 (NSE Scrip Code: TORNTPHARM)

Dear Sir,

Sub.: Presentation to analysts on unaudited Consolidated Financial Results for the quarter

ended 30 1h June, 2022

The presentation on unaudited Consolidated Financial Results for the quarter ended 3 oth June, 2022 to be made to analysts is enclosed for your records.

Thanking you,

Yours sincerely,

For TORRENT PHARMACEUTICALS LIMITED

MARESH AGRAWAL VP (LEGAL) & COMPANY SECRETARY

Encl: A/a

Reg.Ottice : Torrent House, Off Ashram Road, Ahmedabad - 380 009, India. Phone: +91 79 26599000, Fax : +91 79 26582100, www.torrentpharma.com

TORRENT PHARMACEUTICALS LIMITED CIN: L24230GJ1972PLC002126

Q1 FY 2022-23

Revenues: Summary

1

Revenue: Summary

Revenues (Rs cr)

Q1 FY23

Q1 FY22

Gr%

India

United States

Germany

Brazil

Other countries

Others

Total

1,245

1,093

299

214

184

252

154

266

260

153

217

146

2,347

2,134

14%

13%

-18%

20%

16%

6%

10%

2